Elevated messenger RNA expression and plasma protein levels of osteopontin and matrix metalloproteinase types 2 and 9 in patients with ascending aortic.

Slides:



Advertisements
Similar presentations
Resection of ascending aortic aneurysm without use of an interposition aortic graft John S. Ikonomidis, MD, PhD, FRCS(C), Abe DeAnda, MD, D.Craig Miller,
Advertisements

Candidate locus analysis of familial ascending aortic aneurysms and dissections confirms the linkage to the chromosome 5q13-14 in Finnish families  Sakari.
Of mice and men and surgical transcatheter aortic valve insertion
Lost in translation The Journal of Thoracic and Cardiovascular Surgery
Manuel J. Antunes, MD, PhD, DSc 
Response of plasma matrix metalloproteinases and tissue inhibitor of metalloproteinases to stent-graft surgery for descending thoracic aortic aneurysms 
Dysregulated gene expression of extracellular matrix and adhesion molecules in saphenous vein conduits of hemodialysis patients  Yongxin Sun, MD, Wenjun.
Aortic root replacement with a novel decellularized cryopreserved aortic homograft: Postoperative immunoreactivity and early results  Kenton J. Zehr,
Gorav Ailawadi, MD, Christopher W. Moehle, BS, Hong Pei, MD, Sandra P
Doxycycline therapy for abdominal aneurysm: Improved proteolytic balance through reduced neutrophil content  Hazem Abdul-Hussien, MD, Roeland Hanemaaijer,
Takotsubo cardiomyopathy after repair of ruptured abdominal aortic aneurysm  Yukio Umeda, MD, PhD, Yukihiro Matsuno, MD, PhD, Matsuhisa Imaizumi, MD, PhD,
Orally administered dipeptidyl peptidase-4 inhibitor (alogliptin) prevents abdominal aortic aneurysm formation through an antioxidant effect in rats 
Jennifer Chung, MD, MSc, Maral Ouzounian, MD, PhD 
Building a bioartificial heart: A 3-song saga
Victor van Berkel, MD, PhD 
William M. DeCampli, MD, PhD 
A new approach: Ischemic mitral regurgitation guidelines by and for surgeons  Patrick M. McCarthy, MD  The Journal of Thoracic and Cardiovascular Surgery 
How should we treat air leaks?
Go on-pump or off-pump in diabetic patients?
Bicuspid aortic valve aortopathy: One size fits all?
Matrix metalloproteinase and tissue inhibitor expression in atherosclerotic and nonatherosclerotic thoracic aortic aneurysms  Joseph D. Schmoker, MD,
Commentary: Pursuit of the green jacket: Mastery of the long and short games  Daniel P. Raymond, MD  The Journal of Thoracic and Cardiovascular Surgery 
Risk-corrected impact of mechanical versus bioprosthetic valves on long-term mortality after aortic valve replacement  Ole Lund, MD, PhD, Martin Bland,
The lord of the rings  Antonio Miceli, MD, PhD 
Temporal disparity in the induction of matrix metalloproteinases and tissue inhibitors of metalloproteinases after thoracic aortic aneurysm formation 
Candidate locus analysis of familial ascending aortic aneurysms and dissections confirms the linkage to the chromosome 5q13-14 in Finnish families  Sakari.
Transcatheter aortic valve replacement in intermediate-risk patients
Heavy Smoking Before Coronary Surgical Procedures Affects the Native Matrix Metalloproteinase-2 and Matrix Metalloproteinase-9 Gene Expression in Saphenous.
The assessment of cost effectiveness and the effectiveness of cost assessment in cardiothoracic surgery  Vinay Badhwar, MD  The Journal of Thoracic and.
It's not “just a shunt” but sometimes it should be…
A first start for lung transplantation?
Surgery for aortic and mitral valve disease in the United States: A trend of change in surgical practice between 1998 and 2005  Scott D. Barnett, PhD,
Joseph A. Dearani, MD, Michael J. Ackerman, MD, PhD 
Metalloproteinase expression in venous aneurysms
Jeevanantham Rajeswaran, PhD, Eugene H. Blackstone, MD 
Fenton H. McCarthy, MD, MS, Nimesh D. Desai, MD, PhD 
Sinus of Valsalva aneurysms: Stabilizing the repair destabilizing the aortic valve?  M. Sertaç Çiçek, MD, FACC  The Journal of Thoracic and Cardiovascular.
Replicating the success of mitral valve repair in the aortic valve
A fate worse than death  Jennifer S. Lawton, MD 
Attachment disorder in thoracoabdominal surgery
Passing the torch The Journal of Thoracic and Cardiovascular Surgery
Patrick T. Roughneen, MD, Grant T. Fankhauser, MD, Abe DeAnda, MD 
Ralph S. Mosca, MD  The Journal of Thoracic and Cardiovascular Surgery 
Concomitant replacement of the ascending aorta is free—for some
Innovation in cardiothoracic surgical training
The origins of open heart surgery at the University of Minnesota 1951 to 1956  Richard A. DeWall, MD  The Journal of Thoracic and Cardiovascular Surgery 
The Journal of Thoracic and Cardiovascular Surgery
Discussion The Journal of Thoracic and Cardiovascular Surgery
Tissue valve, nitinol stent, or storage solution
The future of cardiac surgery training: A survival guide
The continuing challenge of congenital heart disease in China
Between a rock and a hard place
Matrix metalloproteinase 14 and 19 expression is associated with thoracic aortic aneurysms  Veronica Jackson, MD, Therese Olsson, BMA, Sanela Kurtovic,
Ascending aortitis and aortic valve endocarditis in an infant
Vinay Badhwar, MD, John S. Ikonomidis, MD, PhD, Jeffrey P. Jacobs, MD 
“The more things change…”: The challenges ahead
Toward a more rational approach in treating type B aortic dissection
Evaluating the best approach to treatment of aortic stenosis: The jury is still out  Glen B. Taksler, PhD  The Journal of Thoracic and Cardiovascular Surgery 
Managing conflicts of interest
More than vital: Who bears the burden?
Preoperative PFTs: The answer is blowing in the wind
Did you like Terminator 3 better than Terminator 2
Ascending thoracic aortic aneurysms are associated with compositional remodeling and vessel stiffening but not weakening in age-matched subjects  Dimitrios.
Journal changes and initiatives
Descending thoracic and thoracoabdominal aortic aneurysms: “Busted”
Zone zero thoracic endovascular aortic repair is all about “location, location, location”  Kevin L. Greason, MD  The Journal of Thoracic and Cardiovascular.
Calpain inhibitors: The aspirin of the 21st century?
Zipping up after a median sternotomy: Are we at the end of the wire?
John S. Ikonomidis, MD, PhD, Charlotte R. Ivey, BS, Jason B
Deciding how much to pay for effective care
Presentation transcript:

Elevated messenger RNA expression and plasma protein levels of osteopontin and matrix metalloproteinase types 2 and 9 in patients with ascending aortic aneurysms  Tuija Huusko, MSc, Tuire Salonurmi, PhD, Panu Taskinen, MD, PhD, Johanna Liinamaa, MD, PhD, Tatu Juvonen, MD, PhD, Paavo Pääkkö, MD, PhD, Markku Savolainen, MD, PhD, Sakari Kakko, MD, PhD  The Journal of Thoracic and Cardiovascular Surgery  Volume 145, Issue 4, Pages 1117-1123 (April 2013) DOI: 10.1016/j.jtcvs.2012.04.008 Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 1 Analysis of plasma protein levels of OPN, MMP-2, MMP-9, and TIMP-1. ∗∗∗Statistical significances between aneurysm groups and controls are shown P < .001 (Mann-Whitney U test). AscAA, Ascending aortic aneurysm; AAA, abdominal aortic aneurysm; OPN, osteopontin; MMP-2, matrix metalloproteinase type 2; MMP-9, matrix metalloproteinase type 9; TIMP-1, tissue inhibitor of matrix metalloproteinases type 1. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 1117-1123DOI: (10.1016/j.jtcvs.2012.04.008) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions

Figure 2 Immunostaining study results of OPN and MMP-2 (original magnification ×20). Immunohistochemistry of OPN in AscAA tissue (A) and control tissue (B). Immunoreactivity of MMP-2 in AscAA tissue (C) and in control tissue (D). Histologic features of aortic wall are stained with hematoxylin and eosin. OPN, Osteopontin; MMP-2, matrix metalloproteinase type 2; AscAA, ascending aortic aneurysm. The Journal of Thoracic and Cardiovascular Surgery 2013 145, 1117-1123DOI: (10.1016/j.jtcvs.2012.04.008) Copyright © 2013 The American Association for Thoracic Surgery Terms and Conditions